高级搜索

盆腔炎与卵巢肿瘤发生风险的Meta分析

王子静, 毕学汉, 张梦婷, 杨永秀

王子静, 毕学汉, 张梦婷, 杨永秀. 盆腔炎与卵巢肿瘤发生风险的Meta分析[J]. 肿瘤防治研究, 2015, 42(04): 363-368. DOI: 10.3971/j.issn.1000-8578.2015.04.010
引用本文: 王子静, 毕学汉, 张梦婷, 杨永秀. 盆腔炎与卵巢肿瘤发生风险的Meta分析[J]. 肿瘤防治研究, 2015, 42(04): 363-368. DOI: 10.3971/j.issn.1000-8578.2015.04.010
shu
WANG Zijing, BI Xuehan, ZHANG Mengting, YANG Yongxiu. Pelvic Inflammatory Disease and Risk of Ovarian Tumor: A Meta-analysis[J]. Cancer Research on Prevention and Treatment, 2015, 42(04): 363-368. DOI: 10.3971/j.issn.1000-8578.2015.04.010
Citation: WANG Zijing, BI Xuehan, ZHANG Mengting, YANG Yongxiu. Pelvic Inflammatory Disease and Risk of Ovarian Tumor: A Meta-analysis[J]. Cancer Research on Prevention and Treatment, 2015, 42(04): 363-368. DOI: 10.3971/j.issn.1000-8578.2015.04.010
shu

盆腔炎与卵巢肿瘤发生风险的Meta分析

  • 1. 730000 兰州，兰州大学第一临床医学院；2. 730000兰州，兰州大学第一医院妇产科

基金项目: 甘肃省循证医学与临床转化重点实验室（开放基金）
详细信息
    作者简介:

    王子静（1987-），女，硕士，主要从事妇科肿瘤及内分泌方面的研究

    通讯作者:

    杨永秀，E-mail：yongxiuyang@163.com

  • 中图分类号: R737.31

Pelvic Inflammatory Disease and Risk of Ovarian Tumor: A Meta-analysis

  • The First Clinical Medical College of Lanzhou University﹠Obstetrics and Gynecology, The First Hospital of Lanzhou University, Lanzhou 730000, China

摘要

    摘要
  • 摘要: 目的 Meta分析盆腔炎性疾病（pelvic inflammatory disease，PID）与卵巢肿瘤发病风险的相关性。方法 采用Cochrane系统评价方法，检索PubMed、EMbase、Cochrane Library、中国生物医学文献数据库、中国知网和万方数据库的队列研究及病例-对照研究相关文献。采用RevMan 5.2软件进行统计分析，分别计算纳入队列研究和病例-对照研究的合并优势比（OR）及其95％CI。结果 共纳入2个队列研究和8个病例-对照研究。队列研究Meta分析结果显示，PID暴露可增加卵巢肿瘤的发生风险（OR=1.72，95％CI：1.17~2.52，P=0.006）；病例-对照研究Meta分析结果显示，PID暴露史并未明显增加卵巢肿瘤的发生风险（OR=1.07，95％CI：0.86~1.33，P=0.55）。但有2个研究发现复发性PID可增加卵巢肿瘤的发病风险。结论 队列研究与病例-对照研究的Meta分析结论相矛盾；但有关复发性PID的研究均提示随着PID暴露次数增多卵巢癌的风险也随之增加。鉴于病例-对照研究自身缺陷及队列研究较少，尚需开展更多高质量的前瞻性研究以进一步验证上述结果，尤其是有关复发性或慢性PID与卵巢肿瘤的风险关系。

     

    Abstract: Objective To systematically assess the relationship between pelvic inflammatory disease(PID) and the risk of ovarian tumor．Methods We searched the cohort or case-control studies in PubMed, EMbase, The Cochrane Library, CBM, CNKI and WANFANG(from inception to Oct, 2013). Meta-analysis was performed by RevMan 5.2 software, to assess OR and 95%CI of involved cohort and case-control studies. Results Two cohort studies and eight case-control studies were included. Meta-analysis on cohort studies showed PID could increase the risk of ovarian tumor(OR=1.72, 95％CI:1.17-2.52, P=0.006)．Besides, Metaanalysis of case-control studies showed PID was not associated with the incidence of ovarian tumor (OR=1.07, 95％CI :0.86-1.33, P=0.55). However, two studies found that recurrent PID could increase the risk of ovarian cancer. Conclusion Meta-analysis of cohort studies and case-control studies are inconsistent. However, the risk of ovarian tumor is increased with PID exposure. Because of the limited quantity of case-control studies and too few cohort studies, it needs to develop more high-quality prospective studies to further validate these results, especially about the risk relationship between recurrent or chronic PID and ovarian tumor.

     

    • HTML全文
    • 参考文献(21)
  • [1] Cramer DW. The epidemiology of endometrial and ovarian cancer[J]. Hematol Oncol Clin North Am, 2012, 26(1): 1-12.
    [2] Yang NN, Yan YQ, Zheng RS, et al. An analysis of incidence and mortality for ovarian cancer in China, 2009[J]. Zhongguo Zhong Liu, 2013, 22(8): 617-21. [杨念念, 严亚琼, 郑荣寿, 等. 中国2009 年卵巢癌发病与死亡分析[J]. 中国肿瘤, 2013, 22(8): 617-21.]
    [3] Ness RB, Cottreau C. Possible role of ovarian epithelial inflammation in ovarian cancer[J]. J Natl Cancer Inst, 1999, 91 (17): 1459-67.
    [4] Shu XO, Brinton LA, Gao YT, et al. Population-based case-control study of ovarian cancer in Shanghai[J]. Cancer Res, 1989, 49(13): 36 70-4.
    [5] Booth M, Beral V, Maconochie N, et al. A case-control study of benign ovarian tumours[J]. J Epidemiol Community Health, 1992, 46 (5): 528-31.
    [6] Chen ZX, Liu H, Pan YF, et al. Methods of quality evaluation of medical literatures[J]. Zhongguo Xun Zheng Yi Xue Za Zhi, 2011, 11 (11): 1229-36. [陈泽鑫, 刘慧, 潘益峰, 等. 试验性和观察性 研究相关医学文献质量评价方法[J]. 中国循证医学杂志, 2011, 11 (11): 1229-36.]
    [7] Lin HW, Tu YY, Lin SY, et al. Risk of ovarian cancer in women with pelvic inflammatory disease: a population-based study[J]. Lancet Oncol, 2011, 12(9): 900-4.
    [8] Stewart LM, Holman CD, Finn JC, et al. In vitro fertilization is associated with an increased risk of borderline ovarian tumours[J]. Gynecol Oncol, 2013, 129(2): 372-6.
    [9] Merritt MA, Green AC, Nagle CM, et al. Talcum powder, chronic pelvic inflammation and NSAIDs in relation to risk of epithelial ovarian cancer[J]. Int J Cancer, 2008, 122(1): 170-6.
    [10] Risch HA, Howe GR. Pelvic inflammatory disease and the risk of epithelial ovarian cancer[J]. Cancer Epidemiol Biomarkers Prev, 19 95, 4(5): 447-51.
    [11] Parazzini F, La Vecchia C, Negri E, et al. Pelvic inflammatory disease and risk of ovarian cancer[J]. Cancer Epidemiol Biomarkers Prev, 1996, 5(8): 667-9.
    [12] Ness RB, Grisso JA, Cottreau C, et al. Factors related to inflammation of the ovarian epithelium and risk of ovarian cancer[J]. Epidemiology, 2000, 11(2): 111-7.
    [13] Wu AH, Pearce CL, Tseng CC, et al. Markers of inflammation and risk of ovarian cancer in Los Angeles County[J]. Int J Cancer, 20 09, 124(6): 1409-15.
    [14] Rasmussen CB, Faber MT, Jensen A, et al. Pelvic inflammatory disease and risk of invasive ovarian cancer and ovarian borderline tumors[J]. Cancer Causes Control, 2013, 24(7): 1459-64.
    [15] Shan W, Liu J. Inflammation: a hidden path to breaking the spell of ovarian cancer[J]. Cell Cycle, 2009, 8(19): 3107-11.
    [16] MacciòA, Madeddu C. Inflammation and ovarian cancer[J]. Cytokine, 2012, 58(2): 133-47.
    [17] Li YF, Li RX, Shi SH. Neodoxy of epithelial ovarian cancer cells origin[J]. Xian Dai Fu Chan Ke Jin Zhan, 2013, 22(2): 152-3.[李 艳芳, 李荣霞, 史淑红. 上皮性卵巢癌细胞起源新学说[J]. 现代 妇产科进展, 2013, 22(2): 152-3.]
    [18] Gong TT, Wu QJ, Vogtmann E, et al. Age at menarche and risk of ovarian cancer: a Meta-analysis of epidemiological studies[J]. Int J Cancer, 2013, 132(12): 2894-900.
    [19] Seidman JD, Sherman ME, Bell KA, et al. Salpingitis salpingoliths, and serous tumors of the ovaries: is there a connection?[J]. Int Gynecol Pathol, 2002, 21(2): 101-7.
    [20] Kisielewski R, Tolwinska A, Mazurek A, et al. Inflammation and ovarian cancer--current views[J]. Ginekol Pol, 2013, 84(4): 293-7.
    [21] Kelly AM, Ireland M, Aughey D. Pelvic inflammatory disease in adolescents: high incidence and recurrence rates in an urban teen clinic[J]. J Pediatr Adolesc Gynecol, 2004, 17(6): 383-8.
    • 相关文章
    • 施引文献
    • 资源附件(0)
计量
  • 文章访问数:  1213
  • HTML全文浏览量:  321
  • PDF下载量:  478
  • 被引次数: 0
出版历程
  • 收稿日期:  2013-12-29
  • 修回日期:  2014-08-07
  • 刊出日期:  2015-04-24

目录

摘要
HTML全文
    参考文献(21)
    相关文章
    施引文献
    资源附件(0)

    /

    返回文章
    返回

    联系我们

    地址：武汉市洪山区卓刀泉南路116号（430079）

    电话：027－87670126

    Email：zlfzyjzz@vip.163.com

    This work is licensed under a Creative Commons Attribution 3.0 License.

    邮件订阅 RSS
    总访问量：11624170 今日访问：31930

    版权所有 © 《肿瘤防治研究》编辑部 鄂公网安备 42011102005013号 鄂ICP备2022015867号

    本系统由北京仁和汇智信息技术有限公司开发  百度统计

    x 关闭 永久关闭

    《肿瘤防治研究》杂志关于升级编辑出版系统的通知